Mid-Engined Yaris Makes Belated Super Taikyu Debut – Sportscar365
Mid-Engined Yaris Makes Belated Super Taikyu Debut The Toyota GR Yaris M Concept made its delayed race debut at the Okayama International Circuit. The new machine showed impressive …
$22 million raised to block Zohran Mamdani - Meet 26 billionaires bankrolling his defeat - US News | The Financial Express
Efforts to Block Zohran Mamdani's Campaign Billionaires have invested over $22 million in campaigns to defeat Democratic nominee Zohran Ma…
Novartis to acquire Avidity Biosciences for USD 12 billion
Novartis to Acquire Avidity Biosciences for $12 Billion Novartis has announced an agreement to acquire Avidity Biosciences, a biopharmaceu…
Remarks On Assam CM | Gauhati High Court Extends Interim Protection Granted To Journalist Abhisar Sharma Till November 17
Gauhati High Court Extends Interim Protection for Journalist Abhisar Sharma The Gauhati High Court has extended interim protection for jou…
Still On The Rumoured Coup – The News Chronicle
Rumoured Coup in Nigeria For those who experienced the era of military rule in Nigeria, the mention of a rumoured coup d'etat is significa…
Another Big Week At Spot TV For Accident Attorney Leader | Radio & Television Business Report
Accident Attorney Leader in Spot TV A specialist in accident attorney services with roots in Florida has topped the most-seen spot report …
Novartis signs agreement to buy Avidity Biosciences for $12bn
Novartis Acquires Avidity Biosciences for $12bn Novartis has signed an agreement to acquire all outstanding shares of US-based Avidity Bio…
College Vidya Leads a Nationwide Celebration of Digital Learning and Inclusion: Observes Oct 25th as Online Education Day, making it India's first - Netindia123.com
College Vidya Celebrates Online Education Day College Vidya observed October 25th as Online Education Day, honoring learners, educators, a…
IncludEd Conference: Get Inclusion Ready
IncludEd Conference: Get Inclusion Ready This January, IncludEd is hosting a conference dedicated to Whole-School Inclusion, featuring pra…
Cullinan Therapeutics, Inc.: Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
Cullinan Therapeutics Presents Preclinical Data for CLN-978 Cullinan Therapeutics, Inc. (Nasdaq: CGEM) will present new preclinical data f…
Kyverna Therapeutics, Inc.: Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigator-Initiated Trial Presented at ACR Convergence 2025
Kyverna Therapeutics, Inc. Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigato…